Sonal Kumar

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study

Donghee Kim, Nia Adeniji, Nyann Latt et al. · Clinical Gastroenterology and Hepatology · 2020 · 252 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

Obesity is Associated with Worse Outcomes in COVID‐19: Analysis of Early Data from New York City

Kaveh Hajifathalian, Sonal Kumar, Carolyn Newberry et al. · Obesity · 2020 · 218 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +14

Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications

Kaveh Hajifathalian, Tibor I. Krisko, Amit Mehta et al. · Gastroenterology · 2020 · 155 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14